Compugen Ltd. CGEN

NAS: CGEN | ISIN: IL0010852080 29/10/2025

1,650 USD (-3,51%)

(-3,51%) 29/10/2025

Grafiek Compugen Ltd.

Grafiek Compugen Ltd.

1 dag1d -3,51%
1 week1w -1,20%
1 maand1m 12,24%
3 maanden3m 14,58%
6 maanden6m 3,12%
1 jaar1j 0,61%
5 jaar5j -87,20%

Compugen Ltd. in het nieuws

Toon enkel gratis nieuws

27 oktober 2025 · Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 · Persbericht

13 oktober 2025 · Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 · Persbericht

6 oktober 2025 · Compugen to Present at SITC 2025 · Persbericht

8 september 2025 · Compugen to Present Research at the Single Cell Genomics 2025 Conference · Persbericht

28 augustus 2025 · Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference · Persbericht

6 augustus 2025 · Compugen Reports Second Quarter 2025 Results · Persbericht

28 juli 2025 · Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resistant Ovarian Cancer at ESMO 2025 · Persbericht

23 juli 2025 · Compugen to Release Second Quarter 2025 Results on Wednesday, August 6, 2025 · Persbericht

21 juli 2025 · Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Platinum Sensitive Ovarian Cancer · Persbericht

12 juni 2025 · Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences · Persbericht

Profiel Compugen Ltd.

Gezondheidstechnologie

Website: www.cgen.com

Hoofdzetel: Holon Israël

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe